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ABSTRACT Terrestrial plants have contributed massively to the development of modern oncologic drugs. Despite 
the wide acceptance of Mauritian endemic flowering plants in traditional medicine, scientific evidence of their 
chemotherapeutic potential is lacking. This study aimed to evaluate the in vitro tumor cytotoxicity of leaf 
extracts from five Mauritian endemic medicinal plants, namely Acalypha integrifolia Willd (Euphorbiaceae), 
Labourdonnaisia glauca Bojer (Sapotaceae), Dombeya acutangula Cav. subsp. rosea Friedmann (Malvaceae), 
Gaertnera psychotrioides (DC.) Baker (Rubiaceae), and Eugenia tinifolia Lam (Myrtaceae). The cytotoxicities of 
the extracts were determined against six human cancer cell lines, including cervical adenocarcinoma, colorectal 
carcinoma, oesophageal adenocarcinoma, and oesophageal squamous cell carcinoma. The potent extracts were 
further investigated using cell cycle analysis and reverse phase protein array (RPPA) analysis. The antioxidant 
properties and polyphenolic profile of the potent extracts were also evaluated. Gas chromatography mass spec-
trometry (GC-MS) analyses revealed the presence of (+)-catechin and gallocatechin in E. tinifolia and L. glauca, 
while gallic acid was detected in A. integrifolia. L. glauca, A. integrifolia, and E. tinifolia were highly selective 
towards human oesophageal squamous cell carcinoma (KYSE-30) cells. L. glauca and E. tinifolia arrested KYSE-
30 cells in the G2/M phase, in a concentration-dependent manner. RPPA analysis indicated that the extracts may 
partly exert their tumor growth-inhibitory activity by upregulating the intracellular level of 5′AMP-activated 
kinase (AMPK). The findings highlight the potent antiproliferative activity of three Mauritian endemic leaf 
extracts against oesophageal squamous cell carcinoma and calls for further investigation into their chemother-
apeutic application.
KEYWORDS Mauritian endemic, medicinal plant, oesophageal carcinoma, tumor cytotoxicity, AMPK,
ABBREVIATIONS AMPK – 5′AMP-activated kinase; CCE – cyanidin chloride equivalent; DPPH – 2-2 diphe-
nyl-1-picrylhydrazyl; EDTA – ethylenediaminetetraacetic acid; FRAP – ferric reducing antioxidant power; 
GAE – gallic acid equivalent; GC-MS – gas chromatography coupled to mass spectrometry; HPLC – high-perfor-
mance liquid chromatography; LW – lyophilized weight; mTORC1 – mammalian target of rapamycin complex 
1; OC – oesophageal cancer; QE – quercetin equivalent; RFI – relative fluorescence intensity; RPPA – reverse 
phase protein array; TFC – total flavonoid content; TMSi – trimethylsilylimidazole; TPC – total phenolic content; 
TPrC – total proanthocyanidin content.
82 | ACTA NATURAE |   VOL. 11  № 1 (40)  2019
RESEARCH ARTICLES
INTRODUCTION
Oesophageal cancer (OC) is of increasing global concern 
due to poor prognosis, aggressive disease course, and 
a lack of efficient selective therapeutics. Oesophageal 
squamous cell carcinoma and oesophageal adenocarci-
noma represent the sixth leading cause of cancer death 
worldwide and are associated with a 5-year survival of 
less than 15% and a median overall survival of less than 
a year [1]. Current treatment options rely primarily on 
broad-spectrum cytotoxic chemotherapeutics such as 
cisplatin, fluorouracil, and paclitaxel, which are asso-
ciated with toxic side effects and limited efficacy, in 
addition to resistance [2]. Therefore, there is a dire need 
for searching for novel agents targeted against oesoph-
ageal cancer cells.
Plant-sourced bioactive molecules have provided 
architectural scaffolds for numerous lifesaving clinical 
agents, including 27% of the approved natural antican-
cer drugs, since 1980 [3]. Furthermore, over 3,000 glob-
al plant taxa have documented ethno-medicinal uses in 
the treatment of cancer [4]. 
Mauritius is a biodiversity hotspot located off the 
southeast coast of the African continent in the Indian 
Ocean. To date, the ethno-medicinal uses of about 
32% of Mauritian endemic plants are documented 
with limited insight into their anticancer potential [5]. 
Therefore, this untapped unique resource represents a 
fertile ground for the bioprospecting of novel oncologic 
agents. 
Thus, the present work evaluated the in vitro an-
tioxidant and tumor cytotoxicity of A. integrifolia, 
D. acutangula, E. tinifolia, G. psychotrioides, and 
L. glauca Bojer (Fig. 1), in relation to their polyphenolic 
content. The effect of the three most potent extracts on 
cell cycle progression, mode of induced cell death, and 
their ability to modulate AMPK in oesophageal adeno-
carcinoma cells was also studied.
METHODS
Plant material and preparation of extracts
Fresh leaves of L. glauca, A. integrifolia, and G. psy-
chotrioides were collected at Gaulette serré, near 
Camp Thorel (coordinates 20° 12` 09`` S, 57° 25` 11`` E; 
20° 12` 43`` S, 57° 38` 29`` E and 20° 12` 43`` S, 57° 38` 29`` 
E, respectively), while leaves of E. tinifolia and D. acu-
tangula were collected at lower gorges national park, 
‘Morne Sec’ (coordinates 20° 23` 35`` S, 57° 38` 05`` E) 
and Réduit (coordinates 20° 14` 05`` S, 57° 29` 45`` E), re-
spectively. Dried leaves were exhaustively extracted 
with aqueous methanol (80 %, v/v) and freeze-dried 
as described [6]. 
Estimation of polyphenolic contents 
The Folin-Ciocalteu assay, aluminum chloride assay, 
and HCl/Butan-1-ol assay were used to estimate the 
phenolic, flavonoid, and proanthocyanidin contents, re-
spectively [6]. The results were expressed as mg of gal-
lic acid equivalent (GAE)/g lyophilized weight (LW), 
quercetin equivalent (QE)/gLW, and cyanidin chloride 
equivalent (CCE)/gLW, respectively.
Chromatographic determination of phenolic com-
pounds
The GC-MS analysis of trimethylsilylimidazole derivat-
ized extracts of L. glauca, E. tinifolia and A. integrifolia 
was carried out using an Agilent 7890A gas chromatog-
raphy system (Agilent Technologies, USA) as described 
in [7]. The analysis began with the initial oven tempera-
ture set at 150°C, which increased at the rate of 10°C/min 
to 300°C, and was maintained for another 4–5 min to 
yield a total run of 20 min under constant helium pres-
sure (10 psi). The chromatogram was analyzed by match-
ing the MS spectra of the peaks with those stored in the 
NIST 2011 Mass Spectral Library.
A B
C D E
Fig. 1. The Mauritian endemic medicinal plants under 
study. The Mauritius herbarium voucher specimen bar-
code number is given in brackets ( ). A – A. integrifolia 
(MAU 0016402); B – L. glauca (MAU 0016430);  
C – D. acutangula (MAU 0016638); D – G. psychotri-
oides (MAU 0009450); – E. tinifolia (MAU 0016540)
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In vitro antioxidant capacities of extracts
The in vitro antioxidant activities of the extracts were 
evaluated using ferric reducing antioxidant power 
(FRAP) assay; iron chelating assay; superoxide anion 
radical scavenging assay; and nitric oxide radical inhi-
bition assay, as described in [6]. The modified method 
proposed by Chu et al. [8] was employed for the DPPH 
(2-2 diphenyl-1-picrylhydrazyl) radical scavenging ac-
tivity. Briefly, 100 µl of a methanolic extract (of var-
ying concentration) and 200 µl of 100 µM DPPH dis-
solved in methanol were incubated for 30 min at room 
temperature and the absorbance was read at 492 nm.
The negative and positive controls contained ex-
tract vehicle and gallic acid (or otherwise stated), re-
spectively, instead of the extract. The percentage of 
metal chelating and free radical scavenging activity 
of the extracts were calculated with reference to the 
negative control according to equation 1. A concentra-
tion response curve was generated, and the IC
50
 value 
was determined using the GraphPad Prism 6 software 
(GraphPad Inc., USA). All the experiments were per-
formed in triplicates in three independent assays. 
Equation 1
% Chelating/ Scavenging/ cytotoxic activity = 
=
 (Absorbance negative control – Absorbance extract) ×(Absorbance negative control)
× 100
Human cell cultures
Human cancer cell lines purchased from American 
Type Culture Collection included cervical adenocarci-
noma (HeLa), colorectal carcinoma (HCT 116), oesoph-
ageal adenocarcinoma (OE 33, FLO-1, OE 19 (platinum 
resistant)), and oesophageal squamous cell carcinoma 
(KYSE-30), while non-malignant ones included reti-
nal pigment (RPE-1) and fibroblast (FIBR) cell lines. 
HeLa, HCT 116, FLO-1, RPE-1, and FIBR were grown 
in DMEM, while OE 33, OE 19, and KYSE-30 were cul-
tured in RPMI-1640, both media supplemented with 
10% (v/v) fetal calf serum (FCS), 2 mM L-glutamine, 
1% Penicillin-Streptomycin solution with the medium 
for RPE-1 having an additional supplementation of 20% 
sodium carbonate. The cells were grown under stand-
ard culture conditions. 
Cell proliferation analysis using the metabolic assay
The HeLa, HCT 116, FLO-1, OE 33, OE 19, KYSE-30, 
RPE-1, and FIBR cell lines were plated at 1 × 104 cells 
per well in a 96-well plate and incubated for 24 h be-
fore treatment. The medium was replaced with a fresh 
medium containing the test extracts (0.78, 1.56, 3.13, 
6.25, 12.5, 25 and 50 µg/ml). The experimental nega-
tive and positive controls included 0.1% (v/v, final con-
centration) dimethyl sulfoxide (DMSO) and etoposide 
(0.78, 1.56, 3.13, 6.25, 12.5 and 25 µg/ml), respectively. 
After 24 h, 10 µl of Alamar blue reagent (10% (v/v)) 
was added and the plates were incubated at 37°C for 
4 h. Fluorescence was measured using an excitation 
wavelength of 544 nm and an emission wavelength of 
590 nm in a Synergy H4 Hybrid Multi-Mode Microplate 
Reader (BioTek, USA). Cell viability of the treated cells 
was calculated as a percentage of the number of viable 
cells in the negative control (equation 1) and the IC
50
 
value determined. The results were expressed as the 
mean IC
50 
± SD µg/ml (n=3). The selectivity index (SI) 
values for the test extracts were calculated as the ratio 
of IC
50 
values of RPE-1 cells to cancer cells.
Cell death assay and cell cycle analysis
FLO-1 and KYSE-30 cells were seeded (2.6 × 104 and 
1.8 × 104, respectively) in 384-well Greiner, black, tis-
sue culture plates. The plates were incubated for 24 h 
under standard culture conditions before test extracts 
(L. glauca, E. tinifolia and A. integrifolia) were added 
using a Biomek FX liquid handler (Beckman Coulter 
Inc., USA), to give 6-point dose responses with final as-
say concentrations of 30, 10, 3, 1, 0.3, 0.1 µg/ml with four 
replicates. DMSO and Staurosporine (3, 1, 0.3, 0.1, 0.03, 
0.01 µM) were added as controls. The cells were further 
incubated for 48 h before staining. The media were aspi-
rated from the plate wells and replaced with the stain-
ing mixture (Hoechst 33342 (2 µg/ml, Invitrogen) and 
MitoTracker Deep Red FM (500 nM, Invitrogen)). The 
plates were incubated in the dark (30 min), before wash-
ing three times with PBS. The staining solution was re-
placed with normal media, and the plates were imaged 
on an ImageXpress system (Molecular Devices, UK), 
taking four images per well. The percentage of cells in 
each cell cycle phase was determined using the cell cy-
cle application module within the MetaXpress software 
(Molecular Devices, UK)
Reverse phase protein array (RPPA)
Samples were analyzed by Zeptosens RPPA as de-
scribed previously [9]. Briefly, tumor lysates were nor-
malized to 2 mg/ml with CLB1 lysis buffer and diluted 
1:10 in CSBL1 spotting buffer (Zeptosens-Bayer) prior 
to preparing a final 4-fold concentration series of 0.2, 
0.15, 0.1, and 0.75 mg/ml. The diluted concentration 
series of each sample was printed onto Zeptosens pro-
tein microarray chips (ZeptoChipTM, Zeptosens-Bayer) 
under environmentally controlled conditions (constant 
50% humidity and 14°C) using a non-contact printer 
(Nanoplotter 2.1e, Gesim). A single 400 picoliter drop-
let of each lysate concentration was deposited onto the 
Zeptosens chip (thus representing four spots per single 
biological replicate). A reference grid of AlexaFluor647 
conjugate BSA consisting of four column X 22 rows was 
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spotted onto each subarray; each sample concentration 
series was spotted in between the reference columns. 
After array printing, the arrays were blocked with 
an aerosol of a BSA solution using a custom-designed 
nebulizer device (ZeptoFOGTM, Zeptosen-Bayer) for 1 
h. The protein array chips were subsequently washed 
in double-distilled water and dried prior to performing 
the dual antibody immunoassay comprising 24-hour 
incubation of primary antibody, followed by 2.5-hour 
incubation with the secondary Alexa-Fluor conjugated 
antibody detection reagent (anti-rabbit A647 Fab).
A selected panel of antibodies, pre-validated for 
RPPA application, was used. Following secondary an-
tibody incubation and final wash step in the BSA solu-
tion, the immune stained arrays were imaged using 
the ZeptoREADERTM instrument (Zeptosens-Bayer, 
Germany). For each subarray, five separate images 
were acquired using different exposure times rang-
ing from 0.5-10 s. Microarray images representing the 
longest exposure without saturation of fluorescent sig-
nal detection were automatically selected for analysis 
using the ZeptoViewTM 3.1 software (Zeptosens-Bayer, 
Germany). An error weighted least squares linear fit 
through the fourfold concentration series was used to 
calculate the median relative fluorescence intensity 
(RFI) value for each sample replicate. Local normali-
zation of the sample signal to the reference BSA grid 
was used to compensate for any intra- inter-array/chip 
variation. Local normalized RFI values were used for 
the subsequent analysis, and the data are presented as 
a fold change over DMSO control samples.
Statistical analysis
Statistical analysis was carried out using the GraphPad 
Prism 6 software. The mean values were compared us-
ing One-Way ANOVA. Student’s t-test and/or Tukey’s 
multiple comparisons as the Post Hoc test was used to 
determine the significances of the mean cytotoxic ac-
tivities of phytochemicals and antioxidants among dif-
ferent extracts and the positive control. All charts were 
generated using the Microsoft Excel software (version 
2010).
RESULTS
Phytochemical analysis
The TPC varied significantly between the investigat-
ed leaf extracts (p <0.05), with the highest level meas-
ured in L. glauca (Fig. 2). The TPC in terms of gallic 
acid equivalent ranged from 298.9 ± 9.4 to 110.4 ±13.7 
mg GAE/gLW. G. psychotrioides had the most abun-
dant TPrC in terms of the cyanidin chloride equivalent, 
while a negligible amount was measured in the A. inte-
grifolia leaf extract. The total flavonoid levels ranged 
between 7.6 mg ± 0.3 and 0.4 ± 0.1 mg QE/gLW, with 
D. acutangula having the most prominent flavonoid 
level followed by L. glauca. GC-MS analysis revealed 
the presence of (+)-catechin and gallocatechin in E. ti-
nifolia and L. glauca, while gallic acid was detected 
only in A. integrifolia (Fig. 3).
Antioxidant activities of extracts in in vitro models
The trend in antioxidant potential between the ex-
tracts differed in each of the investigated assays (Table 
1). The FRAP value of L. glauca was significantly 
higher than that of other endemic plant extracts (p< 
0.05), and 2.4-fold lower compared to the positive con-
trol gallic acid (24.9 mmol Fe2+). All the extracts under 
Fig. 2. Total phenolic, flavonoid, and proanthocyanidin 
contents in the investigated extracts. LW – Lyophilized 
weight; CCE – cyanidin chloride equivalent; GAE – gallic 
acid equivalent; QE – quercetin equivalent; TPC – total 
phenolic content; TFC – total flavonoid content; TPrC – 
total proanthocyanidin content. The different superscripts 
between the columns represent a significant difference 
between the extracts (p < 0.05). The data are expressed 
as the mean ± standard deviation (n = 3)
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wards RPE-1 (SI = 2.3) and fibroblast (SI = 1.5) cells 
compared to KYSE-30 cells. The calculated IC
50
 value 
for each extract against the tested cell lines is shown 
in Table 2.
Cell cycle analysis
The cell cycle stage of cells determined using the Cell 
Cycle Application Module within the MetaXpress soft-
ware (Molecular Devices, UK) revealed that the extracts 
affected oesophageal squamous cell carcinoma (KYSE-
30) selectively, showing no changes in the oesophageal 
adenocarcinoma (FLO-1) cell line. Both the E. tinifolia 
and L. glauca extracts exhibited a concentration-de-
pendent effect on the cell cycle (Fig. 4), causing signif-
icant G2/M arrest of KYSE-30 cells, down to 3 µg/ml 
(p< 0.05). Even though the A. integrifolia extract also 
caused cell cycle arrest at G2/M, the effect was less con-
centration-dependent. None of the extracts caused any 
changes in the cell cycle of FLO-1 cells (Fig. 4).
Interestingly, a similar selectivity pattern was ob-
served in the cell death assays. The number of nuclei 
per image was determined using the MetaXpress soft-
ware. Extracts of E. tinifolia and L. glauca induced cell 
death in KYSE-30 cells in a concentration-depend-
ent manner. However, both extracts had no effect on 
FLO-1 cells. The calculated IC
50
 for E. tinifolia against 
KYSE-30 was 1.37 µg/ml; IC
50
 for L. glauca was 1.77 
µg/ml. E. tinifolia at a concentration of 1 µg/ml signif-
icantly decreased the KYSE-30 cell number relative 
to the negative control (p < 0.05), while for L. glauca a 
significant reduction in the cell number was observed 
at 3 µg/ml (p < 0.05) (Fig. 5).
The selective effect on KYSE-30 was based on the 
effects of the extracts on cell morphology (Fig. 6). The 
three extracts had a marked effect on the cell number, 
cell and nuclear morphology, being indicative of cy-
totoxic and cytokinesis defects. However, there were 
Fig. 3. GC Chromatogram of TMSi derivatives of crude 
extracts 
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Table 1. Antioxidant potential of the investigated medicinal plants leaf extracts
Extracts Ferric reducing antioxidant power1
Iron chelating 
activity2
DPPH Scavenging 
activity3
Superoxide 
scavenging activity3
Nitric oxide 
scavenging activity3
A. integrifolia 5.8 ± 0.6d,**** 655.7 ± 50.4a,**** 9.4 ± 0.9c,**** 9.4 ± 2.6b,**** 528.4 ± 18.0b,****
L. glauca 12.1 ± 0.5a,**** 6783.0 ± 1562.0c,* 2.2 ± 0.1a,** 7.6 ± 0.3a,b,* 10.5 ± 1.0a
G. psychotrioides 9.9 ± 0.7b,**** 2189.0 ± 483.3b,**** 2.8 ± 0.3a,**** 6.4 ± 0.6a 21.7 ± 6.4a
E. tinifolia 8.4 ± 0.5c,**** 674.1 ± 87.7a,**** 4.4 ± 0.4b,**** 8.9 ± 1.1b,*** 15.6 ± 2.0a
D. acutangula 3.9 ± 0.4e,**** 1289.0 ± 44.6a,b,**** 9.9 ± 1.3c,**** 23.2 ± 1.6c,**** 43.9 ± 14.0a
Gallic acid 24.9 ± 0.9 8002.0 ± 169.6 (47.0 ± 1.0 mM)
0.7 ± 0.1 
(3.9 ± 0.6 µM)
5.5 ± 0.2 
(32.1 ± 1.3 µM)
9.9 ± 3.4 
(58.4 ± 20.1 µM)
1Values are expressed in mmol Fe2+; 2IC
50 
values are expressed in µg/ml; 3IC
50
values are expressed in µg/ml; Data rep-
resent a mean ± standard deviation (n = 3). Different letters between rows in each column represent significant differ-
ences between the extracts (p < 0.05). Asterisks represent significant differences between the extracts and gallic acid 
(positive control), * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001, **** p ≤ 0.0001.
study showed dose-dependent metal chelating and free 
radical scavenging activity; the IC
50
 values are shown 
in Table 1. L. glauca had the most potent radical scav-
enging activity against DPPH and NO radicals. While 
G. psychotriodes had the highest O
2
.- radical scavenging 
activity, the metal ion chelating activities of A. inte-
grifolia and E. tinifolia were notable compared to those 
of other investigated extracts.
Cytotoxicity of herbal extracts
The A. integrifolia and E. tinifolia extracts exhibited 
dose-dependent growth inhibition of the tested cancer 
cell lines. Both extracts were strongly cytotoxic towards 
KYSE-30 cells and were 6.9- and 5.6-fold, respective-
ly, less toxic with respect to the immortalized normal 
RPE-1 cell line. The chemotherapeutic agent etoposide 
exhibited greater cytotoxicity toward all the tested 
cancer cell lines, relative to the extracts. However, it 
is worth noting that etoposide was more cytotoxic to-
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no apparent morphological changes in the FLO-1 cells 
(Fig. 6).
RPPA results
A selected panel of antibodies, pre-validated for RPPA 
application, was used to compare the individual levels 
of the corresponding proteins in cancer cells treated 
with each of the extracts (at different concentrations) 
with the mock-treated cells. The comparison of the 
RPPA analysis revealed that, at the 3-h time point, 
all three extracts upregulated the level of Thr-172 
phosphorylation of the alpha subunit of AMPK in a 
dose-dependent manner, peaking at 3 µg/ml (Fig. 7), 
suggesting the AMPK pathway of activation in cancer 
cells.
DISCUSSION
The role played by the chemical scaffolds provided 
by terrestrial plants for lifesaving drugs is immense 
[3]. To date, only about 15% of the global plant species 
have been appraised for their curative potential [10]. 
In Mauritius, about 32% of the endemic flora have eth-
nomedicinal uses, although there has been limited sci-
entific validation of their efficacies [5]. The majority 
Table 2: Cytotoxicity (IC
50
 µgLW/ml) of extracts against Human cell lines
Extracts Flo-1 OE 33 OE 19 KYSE-30 HeLa HCT 116 Fibroblast RPE1
A. integrifolia 10.43 ± 2.10[SI = 4.2]c*
28.03 ± 4.21
[SI = 1.6]a****
39.28 ± 7.52
[SI = 1.1]a
6.42 ± 2.21
[SI = 6.9]a
7.67 ± 1.58
[SI = 5.7]a
14.51 ± 1.23
[SI = 3.0]b,c****
36.93 ± 6.41
b****
43.99 ± 4.76
a,b****
D. acutangula 45.72 ± 7.93[SI = 0.8]a**** ND ND ND
14.27 ± 2.97
[SI = 2.6]b****
14.13 ± 2.62
[SI = 2.7]c****
45.30 ± 4.33
a****
37.47 ± 4.50
b****
E. tinifolia 48.62 ± 3.24[SI = 0.8]a****
45.72 ± 7.93
[SI = 0.9]b****
44.65 ± 8.87
[SI = 0.9]b
6.99 ± 0.38
[SI = 5.6]a
35.26 ± 5.01
[SI = 1.1]c****
19.54 ± 5.16
[SI = 2.0]b****
27.04 ± 1.84
c****
38.94 ± 4.10
b****
L. glauca 11.19 ± 2.53[SI = 4.3]c* ND ND
9.22 ± 1.16
[SI = 5.2]b**
41.53 ± 3.28
[SI = 1.2]d****
31.58 ± 5.25
[SI = 1.5]a****
26.74 ± 1.64
c****
48.49 ± 6.12
a****
Etoposide 5.23 ± 0.56[SI = 3.1]
6.74 ± 0.66
[SI = 2.4] ND
7.05 ± 0.89
[SI = 2.3]
5.47 ± 0.66
[SI = 3.0]
4.93 ± 0.35
[SI = 3.3] 10.24 ± 2.77 16.17 ± 3.93
Data represent mean IC
50
 values ± standard deviation (n = 3). Selectivity index determined as a ratio of the IC
50
 immor-
talized RPE-1 normal cell to the IC
50
 of cancer cell lines is indicated. ND = at 50 and 25 µg/ml the extracts and etopo-
side, respectively, failed to induce 50% growth; hence, no IC
50
 value was determined. Different letters between the 
rows in each column represent significant differences between the extracts (p< 0.05). Asterisks represent significant 
differences between the extracts and etoposide (positive control), *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, ****p ≤ 0.0001.
Fig. 4. Cell cycle dis-
tribution after extract 
treatment in the KYSE-30 
and FLO-1 cell lines. Cell 
cycle distribution was 
analyzed by high-content 
microscopy (ImageX-
press-Micro). E. tinifolia 
and L. glauca caused 
significant G2/M arrest 
down to 3 µg/ml (Stu-
dent’s t-test, p < 0.05), 
and the effect caused 
by A. intergrifolia was 
significant at all concen-
trations
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of the untapped endemic species, both medicinal and 
non-medicinal, continue to represent a valuable source 
of novel chemotypes that await discovery. The thera-
peutic benefits of plants are ascribed to their secondary 
metabolites, which are broadly grouped into alkaloids, 
terpenoids, and phenolics, of which the latter represent 
an interesting class [11]. 
A high level of phenolics was estimated in L. glau-
ca, G. psychotriodes, E. tinifolia, and A. integrifolia. 
D. acutangula had the highest flavonoid level, al-
though a low total phenolic content was measured, 
closely followed by L. glauca. The polyphenolic rich-
ness of Mauritian plant extracts has been extensively 
reported on and may be attributed to the high sunlight 
conditions of the island [12]. Furthermore, a number 
of reports have delineated the phenolic composition of 
selected Mauritian endemic plant leaf extracts [13–17]. 
Consistent with the current findings, previous reports 
by Neergheen and co-workers demonstrated the rel-
atively higher abundance of total proanthocyanidin 
Fig. 5. Concentration response graphs for the extracts and Staurosporine control cytotoxicity on the KYSE-30 and FLO-
1 cell lines. The DMSO controls to which the data were normalized were included for reference (data points left of the 
break on the x-axis)
Fig. 6. Fluores-
cence microsco-
py images show-
ing cell number 
and morpho-
logical changes 
in the KYSE-30 
and FLO-1 cells. 
The cells were 
treated with 
the extracts 
(3 µg/ml) and 
Staurosporine 
(0.3 µM) for 48 h 
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compared to total flavonoid components in a G. psy-
chotriodes leaf extract [15, 18]. Moreover, the occur-
rence of flavan-3-ols, namely, (+)-catechin and (-)-ep-
igallocatechin, detected in the E. tinifolia leaf extract 
(Fig. 3) is concordant with findings in the literature [18]. 
Polyphenolic compounds, inclusive of flavan-3-ols de-
rivatives, are extensively documented with regard to 
their antioxidant capacities [11, 19]. 
The pivotal role of plant polyphenols in modulating 
intracellular redox homeostasis and mitigating oxi-
dative stress-induced pathologies is well established 
[19]. Mechanistically, antioxidants may neutralize free 
radicals either by single electron or hydrogen atom 
transfer [20]. The antioxidant capacity of phenolic 
compounds emanates from the presence and degree of 
an electron-donating hydroxyl group on the aromatic 
ring [21]. Polyphenols, for instance flavonoids, are mul-
tifunctional in their antioxidative ability and prevent 
oxidative damage in multiple ways, including free rad-
ical scavenging through direct donation of hydrogen 
atoms, inactivating enzymes due to hydrogen bonding 
of hydroxyl groups to proteins and chelating of the 
metal iron involved in free radical generation, among 
others [22]. Given the diverse mode of action of phenol-
ic antioxidants, the present study employed a battery 
of five independent in vitro models to determine the 
antioxidant potential of the extracts. L. glauca exhibit-
ed the most effective antioxidant capacity in terms of 
ferric-reducing potential and scavenging of DPPH and 
nitric oxide free radicals. The antioxidant capacity of 
the endemic leaf extracts correlated significantly with 
the total phenolic content r = -0.887 (p< 0.05) for DPPH 
free radical scavenging activity and r = 0.970 (p < 0.01) 
for FRAP. The strong correlation between TPC and 
FRAP may be partly attributed to the fact that both 
assays share a similar redox mechanism [23]. Similar 
linear correlation between the TPC and FRAP values 
of Mauritian endemic leaf extracts was previously re-
ported [17]. The positive association between the phe-
nolics and antioxidant activity is not restricted only to 
Mauritian endemic plants, as comparable relationships 
have also been reported for Mauritian citrus fruits [24] 
and Mauritian tea infusate extracts [14]. 
Given the involvement of oxidative stress in the 
multistage carcinogenic process [25], polyphenol-rich 
extracts are expected to prevent or halt the progres-
sion of cancerous cell growth. Polyphenolics are re-
ported to attenuate in vitro cancerous cell growth via 
diverse mechanisms [26]. The in vitro antiproliferative 
potential of selected Mauritian endemic Eugenia and 
Syzygium species against breast cancer cells (MDA-MB 
and MCF-7) has been described earlier [27]. However, 
this study reports for the first time on the growth in-
hibitory activity of Mauritian endemic leaf extracts 
against cervical adenocarcinoma, colorectal carcinoma, 
and oesophageal squamous cell carcinoma. The leaf ex-
tracts of A. integrifolia, L. glauca, and E. tinifolia ex-
hibited dose-dependent growth inhibition against the 
selected cancer cell lines (Table 2). However, oesopha-
geal squamous cell carcinoma KYSE-30 cells were the 
most sensitive to the extracts’ treatment. As per the 
United States National Cancer Institute cytotoxicity 
guidelines, crude extracts having an IC
50
 value below 
20 µg/ml are considered active against tested cell lines 
[28]. In the present study, the calculated IC
50
 values 
ranged between 6.42 and 9.89 µg/ml when KYSE-30 
cells were co-cultured with A. integrifolia, L. glauca, 
and E. tinifolia extracts for 24 h. Furthermore, the se-
lective cytotoxicity of the extracts toward KYSE-30 
cells was fivefold or greater compared to immortalized 
non-malignant normal cells.
Guided by the AlamarBlue™ assay results, the ef-
fects of the three extracts on cell death and cell cycle 
stages of KYSE-30 and FLO-1 cells were further in-
vestigated across a concentration dilution series using 
fluorescence staining and high-content image analy-
sis. The findings indicated that extract treatment for 
48 h induces considerable dose-dependent cell death 
in KYSE-30 cells but not in FLO-1 cells (Figs. 5, 6). A 
similar trend was also observed in cell cycle analysis, 
as extracts treatment induced accumulation of KYSE-
30 cells in the G2/M phase, but no effect on the FLO-1 
cell cycle was apparent (Fig. 4). The blockade of KYSE-
30 cells through G2/M was concentration-dependent 
for both E. tinifolia and L. glauca, while in the case of 
A. integrifolia the effect was less influenced by the ex-
tract dose. 
In cancerous cells, signaling components of different 
cellular pathways are often mutated [29]. In this vein, 
activation of AMPK and subsequent inhibition of the 
mTOR pathway is an area of active research [30]. It was 
previously suggested that activators of AMPK, which 
include plant polyphenols, can interfere with tumor 
growth via cell cycle arrest [31] and apoptosis [32, 33] 
in cancerous cells. The RPPA analysis of the canonical 
signaling pathways that regulate the cell cycle progres-
sion and survival pathways, which in turn regulate cell 
cycle progression and survival, revealed that all three 
extracts increase the level of Thr-172 phosphorylation 
of the alpha subunit of AMPK in KYSE-30 cells (Fig. 
7), suggesting its activation. This study showed for the 
first time that the antiproliferative effect of Mauritian 
endemic medicinal plant leaf extracts is related to their 
influence on the AMPK pathway modulation.
CONCLUSIONS
In conclusion, the specific selectivity of A. integrifolia, 
E. tinifolia, and L. glauca to KYSE-30 oesophageal 
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Fig. 7. Graphs showing the changes in the activated phos-
phorylated AMPK level in the FLO-1 and KYSE-30 cell 
lines. The cells were treated for 3 h at different concentra-
tions. The results represent the ratio of phosphorylated 
to total AMPK levels and are expressed as a fold change 
over DMSO control for each cell type 
squamous cell carcinoma relative to oesophageal 
adenocarcinoma (FLO-1) calls for further investigation 
into the anticancer effect of these medicinal plants. 
This is further substantiated by the G2/M phase cell 
cycle arrest, leading to cell death. AMPK pathway 
modulation following the exposure of KYSE-30 
cells to the extracts provides novel insight into the 
mechanism of action of these leaf extracts as a potential 
chemotherapeutic treatment. This is particularly 
important since esophageal cancer is among the leading 
causes of cancer mortality worldwide as treatment 
is limited due to adverse systemic effects, limited 
efficacy, and emergence of drug resistance. Clinical 
studies with molecularly targeted therapies have so far 
been disappointing, with little improvement in patient 
outcomes. Hence, there is an urgent need to search 
for new effective treatments for oesophageal cancer. 
Although preliminary characterization indicated the 
presence of (+)-catechin and gallocatechin, in-depth 
phytochemical identification is warranted in order to 
identify the AMPK modulator.
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